Compassionate Use of Mylotarg in Combination with FLAG IDA for Relapsed AML Patient (Single Patient IND)

Trial Profile

Compassionate Use of Mylotarg in Combination with FLAG IDA for Relapsed AML Patient (Single Patient IND)

Discontinued
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 10 Sep 2013

At a glance

  • Drugs Cytarabine (Primary) ; Fludarabine (Primary) ; Gemtuzumab ozogamicin (Primary) ; Idarubicin (Primary)
  • Indications Acute myeloid leukaemia; Chronic myeloid leukaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top